Abstract:Aims: The aims of this study were to determine hub genes in glaucoma through multiple machine learning algorithms. Background: Glaucoma has afflicted many patients for many years, with excessive pressure in the eye continuously damaging the nervous system and leading to severe blindness. An effective molecular diagnostic method is currently lacking. objective: The present study attempted to reveal the molecular mechanism and gene regulatory network of hub genes in glaucoma, followed by an attempt to reveal the drug-gene-disease network regulated by hub genes. Objective: The present study attempted to reveal the molecular mechanism and gene regulatory network of hub genes in glaucoma, followed by an attempt to reveal the drug-gene-disease network regulated by hub genes. method: A microarray sequencing dataset (GSE9944) was obtained through the Gene Expression Omnibus database (GEO). The differentially expressed genes in Glaucoma were identified. Based on these genes, we constructed three machine learning models for feature training, Random Forest model (RF), Support Vector Machines model (SVM), and Least absolute shrinkage and selection operator regression model (LASSO). Meanwhile, Weighted Gene Co-Expression Network Analysis (WGCNA) was performed for GSE9944 expression profiles to identify Glaucoma-related genes. The overlapping genes in the four groups were considered as hub genes of Glaucoma. Based on this we also constructed a molecular diagnostic model of Glaucoma. In this study, we also performed molecular docking analysis to explore the gene-drug network targeting hub genes. In addition, we evaluated the immune cell infiltration landscape in Glaucoma samples and normal samples. Methods: A microarray sequencing dataset (GSE9944) was obtained through the Gene Expression Omnibus database. The differentially expressed genes in Glaucoma were identified. Based on these genes, we constructed three machine learning models for feature training, Random Forest model (RF), Least absolute shrinkage and selection operator regression model (LASSO), and Support Vector Machines model (SVM). Meanwhile, Weighted Gene Co-Expression Network Analysis (WGCNA) was performed for GSE9944 expression profiles to identify Glaucoma-related genes. The overlapping genes in the four groups were considered as hub genes of Glaucoma. Based on these genes, we also constructed a molecular diagnostic model of Glaucoma. In this study, we also performed molecular docking analysis to explore the gene-drug network targeting hub genes. In addition, we evaluated the immune cell infiltration landscape in Glaucoma samples and normal samples by applying CIBERSORT method. result: 8 hub genes were determined, ATP6V0D1, PLEC, SLC25A1, HRSP12, PKN1, RHOD, TMEM158, GSN. The diagnostic model composed showed excellent diagnostic performance (area under the curve=1). GSN might positively regulate T cell CD4 naïve as well as negatively regulate T cell regulation (Tregs). In addition, we constructed gene-drug networks in an attempt to explore novel therapeutic agents for Glaucoma. Results: 8 hub genes were determined: ATP6V0D1, PLEC, SLC25A1, HRSP12, PKN1, RHOD, TMEM158 and GSN. The diagnostic model showed excellent diagnostic performance (area under the curve=1). GSN might positively regulate T cell CD4 naïve as well as negatively regulate T cell regulation (Tregs). In addition, we constructed gene-drug networks in an attempt to explore novel therapeutic agents for Glaucoma. Conclusion: Our results systematically determined 8 hub genes and established a molecular diagnostic model that allowed the diagnosis of Glaucoma. Our study provided a basis for future systematic studies of Glaucoma pathogenesis.

Identification of potential core genes in pseudoexfoliation using bioinformatics analysis and retrospective analysis of 84 patients with this disease

Unexpected findings: loss of corneal endothelial cells in Uygur patients with exfoliation syndrome

Proteomic characteristics of the aqueous humor in Uyghur patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma

Exfoliation syndrome and exfoliation glaucoma ‐ Current research and Management in Georgia

Identifying Hub Genes for Glaucoma Based on Bulk RNA Sequencing Data and Multi-machine Learning Models

Identification and Validation of Key Biomarkers and Potential Therapeutic Targets for Primary Open-Angle Glaucoma.

Integrated Bioinformatics-Based Identification and Validation of Neuroinflammation-Related Hub Genes in Primary Open-Angle Glaucoma

Identification of immune-related biomarkers for glaucoma using gene expression profiling

Identification of biomarker candidates for exfoliative glaucoma from autoimmunity profiling

Identification and Verification of Ferroptosis-Related Genes in Keratoconus Using Bioinformatics Analysis

Evaluation of Loxl1 Polymorphisms in Exfoliation Syndrome in A Chinese Population

LOXL1 Hypermethylation in Pseudoexfoliation Syndrome in the Uighur Population

Identification and validation of oxidative stress-related genes in primary open-angle glaucoma by weighted gene co-expression network analysis and machine learning

Identification of Optic Nerve-Related Biomarkers in Primary Open-Angle Glaucoma Based on Comprehensive Bioinformatics and Mendelian Randomization

Genetics of glaucoma

Identifiable Historic and Observable Factors May Predict Progression to Exfoliation Glaucoma in Newly Diagnosed Exfoliation Patients

From onset to blindness: a comprehensive analysis of RPGR-associated X-linked retinopathy in a large cohort in China

Mitochondrial and Microtubule Defects in Exfoliation Glaucoma

Screening of primary open-angle glaucoma diagnostic markers based on immune-related genes and immune infiltration

Screening of Candidate Genes at GLC3B and GLC3C Loci in Chinese Primary Congenital Glaucoma Patients with Targeted Next Generation Sequencing

Comprehensive analysis of genetic and clinical characteristics of 30 patients with X-linked juvenile retinoschisis in China